Carcinomas of the renal pelvis associated with smoking and phenacetin abuse: p53 mutations and polymorphism of carcinogen-metabolising enzymes

International Journal of Cancer

Volumn 79, Issue 5, 1998, Pages 531-536

  Bringuier, Pierre Paul ^a   McCredie, Margaret ^b,c   Sauter, Guido ^d   Bilous, Michael ^e   Stewart, John ^c   Mihatsch, Michael J ^d   Kleihues, Paul ^a   Ohgaki, Hiroko ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b CANCER RESEARCH DIVISION   (Australia)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d UNIVERSITY OF BASEL   (Switzerland)

^e WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PHENACETIN; PROTEIN P53;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CLINICAL ARTICLE; DNA POLYMORPHISM; DRUG ABUSE; FEMALE; GENE MUTATION; GENOTYPE; HUMAN; HUMAN TISSUE; KIDNEY PELVIS CARCINOMA; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SMOKING; TRANSITIONAL CELL CARCINOMA;

AGED; ARYLAMINE N-ACETYLTRANSFERASE; CARCINOGENS; CYTOCHROME P-450 CYP1A1; FEMALE; GENES, P53; GLUTATHIONE TRANSFERASE; HUMANS; ISOENZYMES; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MUTATION; PHENACETIN; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SMOKING; SUBSTANCE-RELATED DISORDERS; SURVIVAL RATE;

EID: 0031715322     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19981023)79:5<531::AID-IJC15>3.0.CO;2-4     Document Type: Article

References (41)

1. ALBERTINI, A.M., HOFER, M., CALOS, M.P. and MILLER, J.H., On the formation of spontaneous deletions: the importance of short sequence homologies in the generation of large deletions. Cell, 29, 319-328 (1982).
2. ANDERSTROM, C., JOHANSSON, S.L. and VON SCHULTZ, L., The influence of phenacetin or mechanical perforation on the development of renal pelvic and urinary bladder tumors in FANFT-induced urinary tract carcinogenesis. Acta pathol. microbiol. immunol. Scand. A., 91, 373-380 (1983).
3. BELL, D.A., STEPHENS, E.A., CASTRANIO, T., UMBACH, D.M., WATSON, M., DEAKIN, M., ELDER, J., HENDRICKSE, C., DUNCAN, H. and STRANGE, R.C., Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer. Cancer Res., 55, 3537-3542 (1995).
4. BELL, D.A., TAYLOR, J.A., PAULSON, D.F., ROBERTSON, C.N., MOHLER, J.L. and LUCIER, G.W., Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione Stransferase M1 (GSTM1) that increases susceptibility to bladder cancer. J. nat. Cancer Inst., 85, 1159-1164 (1993).
5. CAMUS, A.M., FRIESEN, M., CROISY, A. and BARTSCH, H., Species-specific activation of phenacetin into bacterial mutagens by hamster liver enzymes and identification of N-hydroxyphenacetin O-glucuronide as a promutagen in the urine. Cancer Res., 42, 3201-3208 (1982).
6. CORDON CARDO, C., DALBAGNI, G., SAEZ, G.T., OLIVA, M.R., ZHANG, Z.F., ROSAI, J., REUTER, V.E. and PELLICER, A., p53 mutations in human bladder cancer: genotypic versus phenotypic patterns. Int. J. Cancer, 56, 347-353 (1994).
7. DE FLORA, S., Russo, P., PALA, M., FASSINA, G., ZUNINO, A., BENNICELLI, C., ZANACCHI, P., CAMOIRANO, A. and PARODI, S., Assay of phenacetin genotoxicity using in vitro and in vivo test systems. J. Toxicol. environ. Health, 16, 355-377 (1985).
8. ESRIG, D., ELMAJIAN, D., GROSHEN, S., FREEMAN, J.A., STEIN, J.P., CHEN, H S.C., NICHOLS, P.W., SKINNER, D.G., JONES, P.A. and COTE, R.J., Accumulation of nuclear p53 and tumor progression in bladder cancer. N. Engl. J. Med., 331, 1259-1264 (1994).
9. ESRIG, D., SPRUCK, C.H. III, NICHOLS, P.W., CHAIWUN, B., STEVEN, K., GROSHEN, S., CHEN, S.C., SKINNER, D.G., JONES, P.A. and COTE, R.J., p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Amer. J. Pathol, 143, 1389-1397 (1993).
10. FARABAUGH, P.J., SCHMEISSNER, U., HOFER, M. and MILLER, J.H., Genetic studies of the lac repressor. VII. On the molecular nature of spontaneous hotspots in the lacI gene of Escherichia coli. J. Mol. Biol., 126, 847-857 (1978).
11. FUJIMOTO, K., YAMADA, Y., OKAJIMA, E., KAKIZOE, T., SASAKI, H., SUGIMURA, T. and TERADA, M., Frequent association of p53 gene mutation in invasive bladder cancer. Cancer Res., 52, 1393-1398 (1992).
12. FURIHATA, M., YAMASAKI, I., OHTSUKI, Y., SONOBE, H., MORIOKA, M., YAMAMOTO, A., TERAO, N., KUWAHARA, M. and FUJISAKI, N., p53 and human papillomavirus DNA in renal pelvic and ureteral carcinoma including dysplastic lesions. Int. J. Cancer, 64, 298-303 (1995).
13. GREENBLATT, M.S., BENNETT, W.P., HOLLSTEIN, M. and HARRIS, C.C., Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878 (1994).
14. HERMANEK, P. and SABIN, L.H., TNM classification of International Union Against Cancer. TNM Atlas (4th ed.), Springer-Verlag, Berlin (1992).
15. HIRVONEN, A., NYLUND, L., KOCIBA, P., HUSGAFVEL PURSIAINEN, K. and VAINIO, H., Modulation of urinary mutagenicity by genetically determined carcinogen metabolism in smokers. Carcinogenesis, 15, 813-815 (1994).
16. HOLLSTEIN, M.C., RICE, K., GREENBLATT, M.S., SOUSSI, T., FUCHS, R., SORLIE, T., HOVIG, E., SMITH-SORENSEN, B., MONTESANO, R. and HARRIS, C.C., Database of p53 gene somatic mutations in human tumors and cell lines. Nucl., Acids. Res., 22, 3551-3555 (1994).
17. JOHANSSON, S. and WAHLQVIST, L., Tumours of urinary bladder and ureter associated with abuse of phenacetin-containing analgesics. Acta pathol. microbiol. Scand. A., 85, 768-774 (1977).
18. KANNIO, A., RIDANPAA, M., KOSKINEN, H., PARTANEN, T., ANTTILA, S., COLLAN, Y, HIETANEN, E., VAINIO, H. and HUSGAFVEL PURSIAINEN, K., A molecular and epidemiological study on bladder cancer: p53 mutations, tobacco smoking, and occupational exposure to asbestos. Cancer Epidemiol. Biomarkers Prev., 5, 33-39 (1996).
19. KUSSER, W.C., MIAO, X., GLICKMAN, B.W., FRIEDLAND, J.M., ROTHMAN, N., HEMSTREET, O.P., MELLOT, J., SWAN, D.C., SCHULTE, P.A. and HAVES, R.B., p53 mutations in human bladder cancer. Environ. mol. Mutagen., 24, 156-160 (1994).
20. McCREDIE, M., STEWART, J.H., CARTER, J.J., TURNER, J. and MAHONY, J.F., Phenacetin and papillary necrosis: independent risk factors for renal pelvic cancer. Kidney Int., 30, 81-84 (1986).
21. MCCREDIE, M., STEWART, J.H. and DAY, N.E., Different roles for phenacetin and paracetamol in cancer of the kidney and renal pelvis. Int. J. Cancer, 53, 245-249 (1993).
22. MOSTOFI, F.K., SOBIN, L.H. and ToRLONI, H., Histological typing of urinary bladder tumours. In: WHO international histological classification of tumours (10th ed.), World Health Organization, Geneva (1973).
23. NAKANISHI, K., FUKUSHTMA, S., SHIBATA, M., SHIRAI, T., OGISO, T. and ITO, N., Effect of phenacetin and caffeine on the urinary bladder of rats treated with N-buty1-N-(4-hydroxybuty1)nitrosamine. Gann, 69, 395-400 (1978).
24. OHSHIMA, H. and BARTSCH, H., Chronic infections and inflammatory processes as cancer risk factors: possible rote of nitric oxide in carcinogenesis. Mutatation Res., 305, 253-264 (1994).
25. OLDHAM, J.W., PRESTON, R.F. and PAULSON, J.D., Mutagenicity testing of selected analgesics in Ames Salmonella strains. J. appl. Toxicol., 6, 237-243 (1986).
26. PATIERNO, S.R., LEHMAN, N.L., HENDERSON, B.E. and LANDOLPH, J.R., Study of the ability of phenacetin, acetaminophen, and aspirin to induce cytotoxicity. mutation, and morphological transformation in C3H/10T1/2 clone 8 mouse embryo cells. Cancer Res., 49, 1038-1044 (1989).
27. PETERSEN, I., OHGAKI, H., LUDEKE, B.I. and KLEIHUES, P., p53 mutations in phenacetin-associated human urothelial carcinomas. Carcinogenesis, 14, 2119-2122 (1993).
28. PHILLIPS, D.H., DNA adducts in human tissues: biomarkers of exposure to carcinogens in tobacco smoke. Environ. Health Perspect., 104 (Suppl. 3), 453-458 (1996).
29. RICHTER, J., JIANG, F., GOROG, J.P., SARTORIUS, G., EGENTER, C., GASSER, T.C., MOCH, H., MIHATSCH, M.J. and SAUTER, G., Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization. Cancer Res., 57, 2860-2864 (1997).
30. SHACTER, E., BEECHAM, E.J., COVEY, J.M., KOHN, K.W. and POTTER, M., Activated neutrophils induce prolonged DNA damage in neighboring cells. Carcinogenesis, 9, 2297-2304 (1988).
31. SHIELDS, P.G., Pharmacogenetics: detecting sensitive populations. Environ. Health Perspect., 102 (Suppl. 11), 81-87 (1994).
32. SHIELDS, P.G., BOWMAN, E.D., HARRINGTON, A.M., DOAN. V.T. and WESTON, A., Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes. Cancer Res., 53, 3486-3492 (1993).
33. SlDRANSKY, D., VON ESCHENBACH, A., TSAI, Y.C., JONES, P., SUMMERHAYES, I., MARSHALL, F., PAUL, M., GREEN, P., HAMILTON, S.R., FROST, P. and VOGELSTEIN, B., Identification of p53 gene mutations in bladder cancers and urine samples. Science, 252, 706-709 (1991).
34. SPRUCK, C.H. III, RIDEOUT, W.M. III, OLUMI, A.F., OHNESEIT, P.P., YANG, A.S., TSAI, Y.C., NICHOLAS, P.W., HORN, T., HERMANN, G.G., STEVEN, K., Ross, R.K., Yu, M.C. and JONES, P.A. Distinct pattern of p53 mutations in bladder cancer: relationship to tobacco usage. Cancer Res., 53, 1162-1166 (1993).
35. To-FIGUERAS, J., GENE, M., GOMEZ-CATALAN, J., GALAN, M.C., FUENTES, M., RAMON, J.M., RODAMILANS, M., HUGUET, E. and CORBELLA, J., Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) polymorphisms and lung cancer risk among northwestern Mediterraneans. Carcinogenesis, 18, 1529-1533 (1997).
36. UCHIDA, T., WADA, C., ISHIDA, H., WANG, C., EGAWA, S., YOKOYAMA, E., KAMEYA, T. and KOSHIBA, K., p53 mutations and prognosis in bladder tumors. J. Urol., 153, 1097-1104 (1995).
37. VET, J.A., BRINGUIER, P.P., PODDIGHE, P.J., KARTHAUS, H.F., DEBRUYNE, F.M. and SCHALKEN, J.A., p53 mutations have no additional prognostic value over stage in bladder cancer. Brit. J. Cancer, 70, 496-500 (1994).
38. WATANABE, K., TACHIBANA, O., SATO, K., YONEKAWA, Y., KLEIHUES, P. and OHGAKI, H., Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Palhol., 6, 217-224 (1996).
39. WATANABE, R., TOMITA, Y., NISHIYAMA, T., TANIKAWA, T. and SATO, S., Correlation of p53 protein expression in human urothelial transitional cell cancers with malignant potential and patient survival. Int. J. Urol., 1, 43-48 (1994).
40. WILLIAMSON, M.P, ELDER, P.A. and KNOWLES, M.A., The spectrum of TP53 mutations in bladder carcinoma. Genes Chromosomes Cancer, 9, 108-118 (1994).
41. WISEMAN, H. and HALLIWELL, B., Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem. J., 313, 17-29 (1996).